ANN has failed to embrace either the risks associated with the Delta or Omicron strains with the health and safety protection company now trading below its pre-COVID levels and a meaningful 29% below this year’s high. Technically a dip under $30 feels a real possibility but at those levels we believe the risk / reward will look very attractive.
MM is interested in ANN under $30
Add To Hit List
